Case-Based Review

Metastatic Brain Tumors


 

Series Editor: Arthur T. Skarin, MD, FACP, FCCP

Systemic cancer can affect the central nervous system in several different ways, including direct tumor metastasis and indirect remote effects. Intracranial metastasis can involve the skull, dura, and leptomeninges (arachnoid and pia mater), as well as the brain parenchyma. Of these, parenchymal brain metastases are the most common and have been found in as many as 24% of cancer patients in autopsy studies. It has been reported that metastatic brain tumors outnumber primary brain tumors 10 to 1.

To read the full article in PDF:

Click here

Recommended Reading

Lung cancer diagnosis aided by novel plasma protein
MDedge Hematology and Oncology
Cranial radiotherapy for acute lymphoblastic leukemia linked to impaired neurocognition
MDedge Hematology and Oncology
Spare the hippocampus, preserve the memory in whole brain irradiation
MDedge Hematology and Oncology
Study indicates potential for longer survival after radiosurgery for brain metastases
MDedge Hematology and Oncology
Younger adults with brain metastases survive longer with radiosurgery alone
MDedge Hematology and Oncology
CENTRIC results signal end of cilenglitide in glioblastoma
MDedge Hematology and Oncology
Gene panel identifies residual neuroblastoma metastases
MDedge Hematology and Oncology
New chemo regimen is active against recalcitrant neuroendocrine tumors
MDedge Hematology and Oncology
Bevacizumab fails to improve survival in newly diagnosed glioblastoma
MDedge Hematology and Oncology
Primary Brain Tumors
MDedge Hematology and Oncology